Unique Clinical Characteristics and Prognosis of Allopurinol-Induced Severe Cutaneous Adverse Reactions.


Journal

The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220

Informations de publication

Date de publication:
Historique:
received: 14 03 2019
revised: 12 05 2019
accepted: 25 05 2019
pubmed: 16 6 2019
medline: 9 10 2020
entrez: 16 6 2019
Statut: ppublish

Résumé

Allopurinol is the most common cause of severe cutaneous adverse reactions (SCARs) in Korea due to the relatively high prevalence of the HLA-B*58:01 genotype (8%-13%). We aimed to reveal the clinical characteristics and risk factors for death in allopurinol-induced SCARs in Korea. We retrospectively reviewed the medical records of 106 subjects with allopurinol-induced SCARs and 639 subjects with other drug-induced SCARs who were enrolled in the Korean SCARs Registry (collected from 34 nationwide medical institutions) from January 2010 to December 2015. Subjects with allopurinol-induced Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) were older and had more comorbidities, longer latent periods, longer disease durations, more deranged laboratory findings, and increased disease severity resulting in a higher mortality rate (17.6% vs 7.6%; P = .020) compared with the subjects with other drug-induced SCARs. There was no significant difference in age or mortality in drug reaction with eosinophilia and systemic symptoms (DRESS). Subjects with allopurinol-induced SJS/TEN were older and had shorter latent periods and a higher mortality rate (17.6% vs 3.7%; P = .044) than those with allopurinol-induced DRESS. In allopurinol-induced SJS/TEN, significant risk factors for death included chronic renal insufficiency, intensive care unit (ICU) admission, increased blood urea nitrogen levels on admission day, serum peak eosinophil counts, baseline and peak creatinine levels, baseline and peak alanine aminotransferase levels, and decreased lowest platelet counts. In allopurinol-induced DRESS, significant risk factors for death included ICU admission and increased glucose levels on admission day. Allopurinol-induced SCARs have unique characteristics and poor prognoses with important predictive factors of death.

Sections du résumé

BACKGROUND
Allopurinol is the most common cause of severe cutaneous adverse reactions (SCARs) in Korea due to the relatively high prevalence of the HLA-B*58:01 genotype (8%-13%).
OBJECTIVE
We aimed to reveal the clinical characteristics and risk factors for death in allopurinol-induced SCARs in Korea.
METHODS
We retrospectively reviewed the medical records of 106 subjects with allopurinol-induced SCARs and 639 subjects with other drug-induced SCARs who were enrolled in the Korean SCARs Registry (collected from 34 nationwide medical institutions) from January 2010 to December 2015.
RESULTS
Subjects with allopurinol-induced Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) were older and had more comorbidities, longer latent periods, longer disease durations, more deranged laboratory findings, and increased disease severity resulting in a higher mortality rate (17.6% vs 7.6%; P = .020) compared with the subjects with other drug-induced SCARs. There was no significant difference in age or mortality in drug reaction with eosinophilia and systemic symptoms (DRESS). Subjects with allopurinol-induced SJS/TEN were older and had shorter latent periods and a higher mortality rate (17.6% vs 3.7%; P = .044) than those with allopurinol-induced DRESS. In allopurinol-induced SJS/TEN, significant risk factors for death included chronic renal insufficiency, intensive care unit (ICU) admission, increased blood urea nitrogen levels on admission day, serum peak eosinophil counts, baseline and peak creatinine levels, baseline and peak alanine aminotransferase levels, and decreased lowest platelet counts. In allopurinol-induced DRESS, significant risk factors for death included ICU admission and increased glucose levels on admission day.
CONCLUSIONS
Allopurinol-induced SCARs have unique characteristics and poor prognoses with important predictive factors of death.

Identifiants

pubmed: 31201937
pii: S2213-2198(19)30543-4
doi: 10.1016/j.jaip.2019.05.047
pii:
doi:

Substances chimiques

Gout Suppressants 0
HLA-B Antigens 0
Allopurinol 63CZ7GJN5I

Types de publication

Comparative Study Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2739-2749.e3

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Hye Jung Park (HJ)

Department of Internal Medicine, Gangnam Severance Hospital, College of Medicine, Yonsei University, Seoul, Korea.

James Yun (J)

Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

Dong Yoon Kang (DY)

Drug Safety Monitoring Center, Seoul National University Hospital, Seoul, Korea.

Jung-Won Park (JW)

Department of Internal Medicine, College of Medicine, Yonsei University, Seoul, Korea.

Young-Il Koh (YI)

Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

Sujeong Kim (S)

Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.

Sae Hoon Kim (SH)

Department of Internal Medicine, Bundang Hospital, Seoul National University, Seongnam, Korea.

Young Hee Nam (YH)

Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea.

Yi Yeong Jeong (YY)

Department of Internal Medicine, School of Medicine, Gyeongsang National University, Jinju, Korea.

Cheol-Woo Kim (CW)

Department of Internal Medicine, School of Medicine, Inha University, Incheon, Korea.

Hye-Kyung Park (HK)

Department of Internal Medicine, College of Medicine, Pusan National University, Busan, Korea.

Sang Hyon Kim (SH)

Department of Internal Medicine, Dongsan Medical Center, Keimyung University, Daegu, Korea.

Hye-Ryun Kang (HR)

Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Hospital, College of Medicine, Seoul National University, Seoul, Korea.

Jae-Woo Jung (JW)

Department of Internal Medicine, College of Medicine, Chung-Ang University, Seoul, Korea. Electronic address: jwjung@cau.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH